2011 Q4 Form 10-Q Financial Statement

#000117891311003155 Filed on November 21, 2011

View on sec.gov

Income Statement

Concept 2011 Q4 2011 Q3 2010 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin -$360.0K $50.00K $140.0K
YoY Change -376.92% -64.29% 180.0%
% of Gross Profit
Research & Development $340.0K $70.00K $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $10.00K $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses -$20.00K $120.0K $140.0K
YoY Change -115.38% -14.29% 180.0%
Operating Profit
YoY Change
Interest Expense -$30.00K -$40.00K $40.00K
YoY Change -250.0% -200.0% -80.0%
% of Operating Profit
Other Income/Expense, Net -$4.660M -$146.0K $102.0K
YoY Change -243.14%
Pretax Income -$4.670M -$160.0K -$110.0K
YoY Change 4145.45% 45.45% -173.33%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.640M -$822.0K -$420.0K
YoY Change 4118.18% 95.71% -380.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$154.70 -$5.33 -$11.00
COMMON SHARES
Basic Shares Outstanding 11.65M
Diluted Shares Outstanding

Balance Sheet

Concept 2011 Q4 2011 Q3 2010 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $240.0K $20.00K $20.00K
YoY Change -7.69% 0.0% -95.56%
Cash & Equivalents 929.0K ILs $58.00K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables $110.0K $90.00K $10.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets 1.340M ILs $137.0K $30.00K
YoY Change 27.01% 356.67% -94.44%
LONG-TERM ASSETS
Property, Plant & Equipment 225.0K ILs $60.00K $0.00
YoY Change 181.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets 225.0K ILs $9.428M $0.00
YoY Change -16.04%
TOTAL ASSETS
Total Short-Term Assets 1.340M ILs $137.0K $30.00K
Total Long-Term Assets 225.0K ILs $9.428M $0.00
Total Assets 1.565M ILs $9.565M $30.00K
YoY Change 18.29% 31783.33% -94.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $420.0K $60.00K $210.0K
YoY Change 223.08% -71.43% -61.11%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $300.0K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities 2.933M ILs $3.852M $870.0K
YoY Change 539.0% 342.76% 61.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $230.0K $0.00
YoY Change
Other Long-Term Liabilities $60.00K $90.00K
YoY Change -33.33%
Total Long-Term Liabilities 177.0K ILs $320.0K $0.00
YoY Change -82.96% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities 2.933M ILs $3.852M $870.0K
Total Long-Term Liabilities 177.0K ILs $320.0K $0.00
Total Liabilities 3.110M ILs $370.0K $870.0K
YoY Change 107.61% -57.47% -83.14%
SHAREHOLDERS EQUITY
Retained Earnings -10.16M ILs -$186.7M
YoY Change 11.43%
Common Stock 87.00K ILs $43.00K
YoY Change 128.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -1.545M ILs $5.713M -$830.0K
YoY Change
Total Liabilities & Shareholders Equity 1.565M ILs $9.565M $30.00K
YoY Change 18.29% 31783.33% -94.44%

Cashflow Statement

Concept 2011 Q4 2011 Q3 2010 Q3
OPERATING ACTIVITIES
Net Income -$4.640M -$822.0K -$420.0K
YoY Change 4118.18% 95.71% -380.0%
Depreciation, Depletion And Amortization $0.00 $10.00K $0.00
YoY Change -100.0%
Cash From Operating Activities -$100.0K -$120.0K -$30.00K
YoY Change -70.59% 300.0% -83.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $170.0K $0.00 $0.00
YoY Change -383.33%
Cash From Investing Activities $170.0K $0.00 $0.00
YoY Change -383.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 180.0K 100.0K 10.00K
YoY Change -75.34% 900.0%
NET CHANGE
Cash From Operating Activities -100.0K -120.0K -30.00K
Cash From Investing Activities 170.0K 0.000 0.000
Cash From Financing Activities 180.0K 100.0K 10.00K
Net Change In Cash 250.0K -20.00K -20.00K
YoY Change -24.24% 0.0% -88.89%
FREE CASH FLOW
Cash From Operating Activities -$100.0K -$120.0K -$30.00K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$120.0K -$30.00K
YoY Change 300.0% -83.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010 topmd Receipts On Account Of Shares
ReceiptsOnAccountOfShares
1518000 USD
topmd Receive Shares Of Investment In Affiliated Company
ReceiveSharesOfInvestmentInAffiliatedCompany
9538000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Document Period End Date
DocumentPeriodEndDate
2011-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001211805
CY2011Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11645405
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
TOPSPIN MEDICAL INC
CY2011Q3 topmd Capital Fund
CapitalFund
9538000 USD
CY2010Q4 topmd Capital Fund
CapitalFund
USD
CY2011Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11645405
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1522942
CY2009Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
CY2011Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11645405
CY2011Q3 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
11645405
topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
9958328
CY2010Q3 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
1522942
topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
1522942
CY2010 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
1522942
CY2011Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
182788000 USD
CY2010Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181015000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
80000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1964000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-219000 USD
CY2010 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-255000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
41000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
USD
CY2010 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
-24000 USD
CY2011Q3 us-gaap Assets
Assets
9565000 USD
CY2010Q4 us-gaap Assets
Assets
82000 USD
CY2011Q3 us-gaap Assets Current
AssetsCurrent
137000 USD
CY2010Q4 us-gaap Assets Current
AssetsCurrent
82000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> <!--StartFragment--> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 54pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> NOTE 3:-</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine-month period ended September 30, 2011 are not necessarily indicative of the results that may be expected for the year ended December&nbsp;31, 2011.</div> <!--EndFragment--></div> </div>
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33000 USD
CY2010Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1002000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-33000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-944000 USD
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-969000 USD
CY2011Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1522942
CY2011Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
USD
CY2010Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
1518000 USD
CY2011Q3 us-gaap Common Stock Value
CommonStockValue
43000 USD
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
USD
CY2010 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1518000 USD
CY2011Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
1312000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
1254000 USD
us-gaap Depreciation
Depreciation
USD
us-gaap Depreciation
Depreciation
4000 USD
CY2010 us-gaap Depreciation
Depreciation
9000 USD
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2010Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.23
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.52
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
566000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1983000 USD
CY2010Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
522000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1997000 USD
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2512000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
757000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-60000 USD
CY2010 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
518000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
USD
CY2010 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1101000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-358000 USD
CY2010 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1028000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
88000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-198000 USD
CY2010 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-193000 USD
us-gaap Increase Decrease In Restricted Cash And Investments For Operating Activities
IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities
USD
us-gaap Increase Decrease In Restricted Cash And Investments For Operating Activities
IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities
-52000 USD
CY2010 us-gaap Increase Decrease In Restricted Cash And Investments For Operating Activities
IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities
-59000 USD
CY2011Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1415000 USD
CY2010Q4 us-gaap Interest Payable Current
InterestPayableCurrent
658000 USD
CY2011Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
9428000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-260000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2098000 USD
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2570000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-822000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2224000 USD
CY2010Q3 us-gaap Net Income Loss
NetIncomeLoss
-420000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1879000 USD
CY2010Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
USD
CY2011Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9565000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82000 USD
CY2011Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3852000 USD
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1975000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
227000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1102000 USD
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1542000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
52000 USD
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
59000 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-2315000 USD
CY2011Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
110000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
110000 USD
CY2010Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
CY2010 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-131000 USD
CY2010Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
102000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
118000 USD
CY2010 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
197000 USD
CY2011Q3 us-gaap Notes Payable Current
NotesPayableCurrent
481000 USD
CY2010Q4 us-gaap Notes Payable Current
NotesPayableCurrent
USD
CY2011Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
644000 USD
CY2010Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
63000 USD
CY2011Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
137000 USD
CY2010Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
208000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
19000 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1102000 USD
CY2010 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1542000 USD
CY2011Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186656000 USD
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-184432000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
43000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-3000 USD
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
80000 USD
CY2011Q3 us-gaap Stockholders Equity
StockholdersEquity
5713000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-1893000 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-1176000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
249000 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1518000 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
USD
CY2010 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
USD

Files In Submission

Name View Source Status
0001178913-11-003155-index-headers.html Edgar Link pending
0001178913-11-003155-index.html Edgar Link pending
0001178913-11-003155.txt Edgar Link pending
0001178913-11-003155-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
topmd-20110930.xml Edgar Link completed
topmd-20110930.xsd Edgar Link pending
topmd-20110930_cal.xml Edgar Link unprocessable
topmd-20110930_def.xml Edgar Link unprocessable
topmd-20110930_lab.xml Edgar Link unprocessable
topmd-20110930_pre.xml Edgar Link unprocessable
zk1110673.htm Edgar Link pending